LOVENOX®-: Treatment for Deep Vein Thrombosis (DVT) Blood Clots

Links shared publicly online about this topic.

  • 1,548
    total visits

LOVENOX®-: Treatment for Deep Vein Thrombosis (DVT) Blood Clots

lovenox.com

LOVENOX® is an anticoagulant therapy indicated to help reduce the risk of developing DVT, or deep vein thrombosis, which may lead to pulmonary embolism (PE)

View full resource at lovenox.com

Tags: Blood Clot, Anti-Clotting Medication, Anticoagulant, Lovenox, Sanofi-Aventis, Pulmonology, #HCSM, #HCMKTG

  • Share

Most Recently Shared on December 7, 2009 at 4:12 pm By:

healthblawg David Harlow

For @RosettaHC & others keeping score at home re Sanofi-Aventis Lovenox #sidewiki http://j.mp/6TtjFR Legal:1, Mktg:0 #hcsm #hcmktg #pbecomm

2 years ago...

Comments of using Lovenox (study 6064699) - eHealthMe.com

ehealthme.com — “Was on 40mg lovenox for 5 days after surgery, and menstrual had started 4 days prior to taking lovenox and 15 days later I am still menstruating.View full resource at ehealthme.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 12:29 am By:

eHealthMe eHealthMe.com Health Site

Was on 40mg lovenox for 5 days after surgery, and menstrual had started 4 days prior to taking lovenox and 15 http://t.co/VqnN7b0O

1 month ago...

Lovenox For 1 1/2 Yrs (Newest posts first) - The People's Medicine Community

prescriptiondrug-info.com — “I have been taking Lovenox for 1 1 2 years for a DVT ankle to groin and multiple clots in my lungs all four quadrants No one can figure out WHY I grew the super clot it did not reabsorb and is still there I had a Tulip filter put in before surgery remove ovary because suspected cancer pathology was (Newest posts first)View full resource at prescriptiondrug-info.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 5:35 am By:

druginfo Medicine Community Support

" I have been taking Lovenox for 1 1/2 years for a DVT (ankle to groin) and multiple clots in my lungs (all fo http://t.co/6f1Qs8Xh

1 month ago...

FDA Approves Generic Lovenox - WSJ.com

online.wsj.com — “A California biotechnology company won FDA approval to sell a generic version of the blockbuster blood thinner Lovenox, following a years-long battle that was unusually bitter.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 5:22 am By:

MedicalFeed MedicalFeed Health News Feed

New Generic Lovenox Receives FDA Approval: A California biotechnology company won FDA… http://t.co/od2YFrt7

7 months ago...

FDA Approves Watson Pharmaceuticals Generic Lovenox (Enoxaparin) - Forbes

forbes.com — “The FDA has granted approval to Amphastar's generic version of Lovenox (enoxaparin sodium), Watson Pharmaceuticals has announced. The low molecular weight heparin will be sold by Watson under an arrangement with Amphastar. In July 2010 the FDA approved the first generic version of enoxaparin, manufactured by Sandoz and marketed in the US [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on September 19, 2011 at 11:29 pm By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves Watson Pharmaceuticals Generic Lovenox (Enoxaparin): The FDA has granted approval to Ampha... http://t.co/EArfuZXO #drug

7 months ago...

lovenox - Lap Band Talk Forums

lapbandtalk.com — “I have an autoimmune disease called Antiphospholipid Syndrome, also known as APS, that causes my blood to clot abnormally. I've been taking Love...View full resource at lapbandtalk.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 5:09 am By:

theheart.org: trusted cardiology news and opinions

theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on May 27, 2011 at 6:05 pm By:

theheartorg Shelley Wood Cardiology

Senate finance committee implies Sanofi paid petitioners to help delay generic Lovenox: A new report from the Se... http://bit.ly/ki3tlr

11 months ago...

Sanofi-Aventis, Medtronic under scrutiny in press reports

news-medical.net — “ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 27, 2011 at 10:38 am By:

NewsMedical News-Medical.Net Health News

Sanofi-Aventis, Medtronic under scrutiny in press reports: ProPublica details alleged activities by Sanofi-Avent... http://bit.ly/mg4cPW

11 months ago...

Sanofi-Aventis, Medtronic Under Scrutiny In Press Reports - Kaiser Health News

kaiserhealthnews.org — “ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.View full resource at kaiserhealthnews.org

  • View Related
  • Share

Most Recently Shared on May 26, 2011 at 2:20 pm By:

Sanofi Pays Doctors to Dis Generic Version of Lovenox - Pharma Marketing Network Forums

forums.pharma-mkting.com — “Sanofi Pays Doctors to Dis Generic Version of Lovenox Industry NewsView full resource at forums.pharma-mkting.com

  • View Related
  • Share

Most Recently Shared on May 25, 2011 at 2:57 pm By:

pharmaguy John Mack Health Executive

Find Senate letter & report re Sanofi "strategic use" of physicians to dis generic version of Levenox here: http://ow.ly/52Ilr

11 months ago...

Senate Panel Hits Sanofi Payments - WSJ.com

online.wsj.com — “Sanofi contributed to two medical groups and a researcher that encouraged regulators to delay approval of a drug that would undercut its Lovenox, according to a Senate panel report.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on May 25, 2011 at 10:30 am By:

KentBottles Kent Bottles, MD Physician, Doctor, and Pathologist

http://ow.ly/52tUa US Senate criticizes Sanofi for $5 million to med groups that encouraged regulators to slow approval of drug

11 months ago...

Lovenox and pumps - TuDiabetes

tudiabetes.org — “I most likely be on Lovenox (injections) which is a blood thinner like Heparin not Coumadin. I am one and million that is allergic to Coumadin. I am planning o--View full resource at tudiabetes.org

  • View Related
  • Share

Most Recently Shared on April 7, 2011 at 1:15 am By:

tudiabetes a diabetes community Support

Insulin pumps: Lovenox and pumps: I most likely be on Lovenox (injections) which is a blood thinner like Hepari... http://tud4.us/f44haG

1 year ago...

Medical News: ACC: Mixed Results for Factor Xa Drug in Medical Ward - in Meeting Coverage, ACC from MedPage Today

medpagetoday.com — “NEW ORLEANS -- An extended course of the novel anticoagulant rivaroxaban (Xarelto) may prevent venous thromboembolism better than a standard course of enoxaparin (Lovenox) in acutely-ill medical patieView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on April 6, 2011 at 5:29 pm By:

MedicalFeed MedicalFeed Health News Feed

ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE): NEW ORLEANS (MedPage Today… http://goo.gl/fb/1y978

1 year ago...

ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “NEW ORLEANS (MedPage Today) -- An extended course of the novel anticoagulant rivaroxaban (Xarelto) may prevent venous thromboembolism better than a standard course of enoxaparin (Lovenox) in acutely-ill medical patients, but at the cost of more bleeding, researchers found.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on April 6, 2011 at 4:35 pm By:

MedicalFeed MedicalFeed Health News Feed

ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE): NEW ORLEANS (MedPage Today) -- An extended course ... http://bit.ly/enJgQe

1 year ago...

Medical News: ACC: Mixed Results for Factor Xa Drug in Medical Ward - in Meeting Coverage, ACC from MedPage Today

medpagetoday.com — “NEW ORLEANS -- An extended course of the novel anticoagulant rivaroxaban (Xarelto) may prevent venous thromboembolism better than a standard course of enoxaparin (Lovenox) in acutely-ill medical patieView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on April 6, 2011 at 4:20 pm By:

MedicalNews Medical News Health News

ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE) http://bit.ly/gpxYml

1 year ago...

DAVOS-UPDATE 1-Sanofi CEO sees progress in Genzyme talks | Reuters

reuters.com — “* No meetings planned but CEOs may run into other in Davos * Sanofi CEO says CVR could offer significant value * Sanofi already braced for generic Lovenox from Teva (Adds further quotes, detailView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 26, 2011 at 11:24 am By:

reutersBenHir Ben Hirschler Health Communicator

Sanofi's Viehbacher tells Reuters there's progress in Genzyme talks - may run into Termeer in #Davos #WEF $GENZ http://reut.rs/e9GpvL

1 year ago...

Advertisement